Mereo BioPharma (MREO) Research & Development (2023 - 2025)
Historic Research & Development for Mereo BioPharma (MREO) over the last 3 years, with Q3 2025 value amounting to $4.3 million.
- Mereo BioPharma's Research & Development rose 3470.03% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year increase of 3239.92%. This contributed to the annual value of $20.9 million for FY2024, which is 2016.3% up from last year.
- According to the latest figures from Q3 2025, Mereo BioPharma's Research & Development is $4.3 million, which was up 3470.03% from $5.4 million recorded in Q2 2025.
- Over the past 5 years, Mereo BioPharma's Research & Development peaked at $8.8 million during Q4 2024, and registered a low of $3.2 million during Q3 2024.
- Over the past 3 years, Mereo BioPharma's median Research & Development value was $4.3 million (recorded in 2025), while the average stood at $4.7 million.
- Examining YoY changes over the last 5 years, Mereo BioPharma's Research & Development showed a top increase of 8361.78% in 2024 and a maximum decrease of 2474.09% in 2024.
- Over the past 3 years, Mereo BioPharma's Research & Development (Quarter) stood at $4.8 million in 2023, then soared by 83.62% to $8.8 million in 2024, then tumbled by 51.59% to $4.3 million in 2025.
- Its last three reported values are $4.3 million in Q3 2025, $5.4 million for Q2 2025, and $3.9 million during Q1 2025.